Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
77,770,935
-
Share change
-
+20,140,784
-
Total reported value
-
$1,312,527,807
-
Put/Call ratio
-
19%
-
Price per share
-
$16.90
-
Number of holders
-
120
-
Value change
-
+$341,021,805
-
Number of buys
-
93
-
Number of sells
-
24
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q1 2018
As of 31 Mar 2018,
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,770,935 shares.
The largest 10 holders included
venBio Select Advisor LLC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, ACUTA CAPITAL PARTNERS, LLC, FARALLON CAPITAL MANAGEMENT LLC, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, and Consonance Capital Management LP.
This page lists
120
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.